WHO expert consultation on rabies

World Health Organization - Technical Report Series

Volumn , Issue 931, 2005, Pages

  Briggs, D ^a   Bourhy, H ^b,c   Cleaveland, S ^d   Cliquet, F ^e,f   Ertl, H ^g,h   Fayaz, A ^i,j   Fooks, A ^k,l   Hemachudha, T ^m   Ichhpujani, R L ⁿ   Kaboyo, W R ^o   Koprowski, H ^p,q   Madhusudana, S N ^r,s   Muller T ^t,u   Nel, L ^v   Quiambao, B ^w   Rupprecht, C E ^x,y   Salahuddin, N ^z   Sudarshan, M K ^aa   Tordo, N ^b   Wandeler, A I ^ab,ac   Wilde, H ^ad,ae   Spinola, F ^af   Belotto, A ^ag   Bhatia, R ^ah   Endo, H ^ai   Ganter, B ^aj   Gibert, R ^ak   Grachev, V ^al   Knezevic, I ^am   Mc Adams, D ^an   Meslin, F X ^ai   Miranda, E ^ao   Morgeaux, Sylvie ^ak   Roungou, J B ^ap   more..

^a KANSAS STATE UNIVERSITY   (United States)

^b INSTITUT PASTEUR   (France)

^c WHO Collaborating Centre for Reference and Research on Rabies   (France)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Research Laboratory on Rabies and Wild Animal Diseases   (France)

^f Healthy Pigs Production and Experimentation Section   (France)

^g WISTAR INSTITUTE   (United States)

^h WHO Collaborating Centre for Reference and Research on Rabies   (United States)

ⁱ PASTEUR INSTITUTE OF IRAN   (Iran)

^j Isfahan Cardiovascular Research Center   (Iran)

^k VETERINARY LABORATORIES AGENCY   (United Kingdom)

^l WHO Collaborating Centre for the Characterization of Rabies and Rabies related Viruses   (United Kingdom)

^m KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

ⁿ GOVERNMENT OF INDIA   (India)

^o MINISTRY OF HEALTH   (Uganda)

^p THOMAS JEFFERSON UNIVERSITY   (United States)

^q WHO Collaborating Centre for Neurovirology   (United States)

^r NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^s WHO Collaborating Centre for Reference and Research in Rabies   (India)

^t Institute of Epidemiology   (Germany)

^u WHO Collaborating Centre for Rabies Surveillance and Research   (Germany)

^v UNIVERSITY OF PRETORIA   (South Africa)

^w RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^x CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^y WHO Collaborating Centre for Reference and Research on Rabies   (United States)

^z CIVIL HOSPITAL   (Pakistan)

^aa KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES   (India)

^ab Ottawa Laboratory Fallowfield   (Canada)

^ac WHO Collaborating Centre for Control Pathogenesis and Epidemiology of Rabies in Carnivores   (Canada)

^ad CHULALONGKORN UNIVERSITY   (Thailand)

^ae THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^af Marwar Trust   (Switzerland)

^ag PAN AMERICAN HEALTH ORGANIZATION   (United States)

^ah WHO Regional Office for South East Asia   (India)

^ai WORLD HEALTH ORGANIZATION   (Switzerland)

^aj WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^ak AFSSAPS   (France)

^al CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

^am Family and Community Health   (Switzerland)

^an Grand Saconnex   (Switzerland)

^ao The World Health Organization Regional Office for the Western Pacific philippines   (Philippines)

^ap WHO Regional Office for Africa   (Zimbabwe)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; COMPLEMENTARY DNA; INACTIVATED VACCINE; LIVE VACCINE; METHISOPRINOL; POVIDONE IODINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; RECOMBINANT VACCINE; RIBAVIRIN; STEROID; THYMOCYTE ANTIBODY; VIDARABINE; VIRUS RNA;

ANTIBODY TITER; ANTIGEN DETECTION; AUTOPSY; BAT; BRAIN BIOPSY; CADAVER; CARNIVORE; DISABLED PERSON; DISEASE TRANSMISSION; DOG; DOMESTIC ANIMAL; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INJECTION SITE ERYTHEMA; INJECTION SITE PRURITUS; LABORATORY DIAGNOSIS; LAW ENFORCEMENT; LIVESTOCK; MASS IMMUNIZATION; NONHUMAN; ORGAN TRANSPLANTATION; PASSIVE IMMUNIZATION; PROTECTIVE CLOTHING; RABIES; RABIES VIRUS; REVIEW; RODENT; VACCINATION; VIRUS CLASSIFICATION; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS STRAIN; VIRUS TRANSMISSION; WILDLIFE; WORLD HEALTH ORGANIZATION; WOUND CARE; WOUND INFECTION;

EID: 31944438838     PISSN: 05123054     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (67)

1. WHO Expert Committee on Rabies. Eighth report. Geneva, World Health Organization, 1992 (WHO Technical Report Series, No. 824).
2. Cleaveland S et al. Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries. Bulletin of the World Health Organization, 2002, 80:304-310.
3. Knobel DL et al. Re-evaluating the burden of rabies in Africa and Asia. Bulletin of the World health Organization, 2005, 83(5):360-368.
4. Assessing the burden of rabies in India. WHO sponsored national multicentric rabies survey 2003. Final report. August 2003. Bangalore, Association for Prevention and Control of Rabies in India (APCRI), 2003.
5. Aubert MF. Costs and benefits of rabies control in wildlife in France. Revue Scientifique et Technique (International Office of Epizootics), 1999, 18(2):533-543.
6. IX REDIPIRA meeting of directors of national programs for rabies control in Latin America. Final report. Santa Cruz de las Sierra, Bolivia, October 7-9, 2002. Washington, DC, Pan American Health Organization, 2003.
7. Meslin FX, Kaplan MM, Koprowski H, eds. Laboratory techniques in rabies, 4th ed. Geneva, World Health Organization, 1996.
8. Tordo N et al. Rhabdoviridae. In: Fauquet CM et al., eds, Virus taxonomy, VIIIth Report of the International Committee on Taxonomy of Viruses. London, Elsevier/Academic Press, 2004:623-644.
9. Badrane H et al. Evidence of two lyssavirus phylogroups with distinct pathogenicity and immunogenicity. Journal of Virology, 2001, 75:3268-3276.
10. Nadin-Davis SA et al. Lyssavirus P gene characterisation provides insights into the phylogeny of the genus and identifies structural similarities and diversity within the encoded phosphoprotein. Virology, 2002, 298:286-305.
11. Botvinkin AD et al. Novel lyssaviruses isolated from bats in Russia. Emerging Infectious Diseases, 2003, 9:1623-1625.
12. Mitrabhakdi E et al. Difference in neuropathogenetic mechanisms in human furious and paralytic rabies. Journal of the Neurological Sciences (in press).
13. Rupprecht CE, Hemachudha T. Rabies. In: Scheid M, Whitley RJ, Marra C, eds. Infections of the central nervous system. Philadelphia, Lippincott, Williams & Wilkins, 2004:243-259.
14. Laothamatas J et al. MR imaging in human rabies. AJNR. American Journal of Neuroradiology, 2003, 24:1102-1109.
15. Transport of infectious substances. Geneva, World Health Organization, 2004 (WHO/CDS/CSR/LYO/2004.9; http://www.who.int/csr/resources/publications/ WHO_CDS_CSR_LYO_2004_9, accessed 31 March 2005).
16. Hirose JA, Bourhy H, Sureau P. Retro-orbital route for the collection of brain specimens for rabies diagnosis. Veterinary Record, 1991, 129:291-292.
17. Tong TR et al. Trucut needle biopsy through superior orbital fissure for the diagnosis of rabies. Lancet, 1999, 354 (9196):2137-2138.
18. Manual of diagnostic tests and vaccines for terrestrial animals, 5th ed. Paris, World Organisation for Animal Health, 2004 (http://www.oie.int/eng/ normes/mmanual/A_00044.htm, accessed 31 March 2005).
19. Bourhy H et al. Comparative field evaluation of the fluorescent-antibody test, virus isolation from tissue culture, and enzyme immunodiagnosis for rapid diagnosis of rabies. Journal of Clinical Microbiology, 1989, 27:519-523.
20. Hemachudha T, Wacharapluesadee S. Ante-mortem diagnosis of human rabies. Clinical Infectious Diseases, 2004, 39:1085-1086.
21. Crepin P et al. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. Journal of Clinical Microbiology, 1998, 36:1117-1121.
22. Jackson AC et al. Management of rabies in humans. Clinical Infectious Diseases, 2003, 36:60-63.
23. Requirements for rabies vaccine for human use. In: WHO Expert Committee on Biological Standardization. Thirty-first report. Geneva, World Health Organization, 1981, Annex 2 (WHO Technical Report Series, No. 658).
24. WHO Expert Committee on Biological Standardization. Thirty-ninth report. Geneva, World Health Organization, 1987 (WHO Technical Report Series, No. 760).
25. Requirements for rabies vaccine for human use. In: WHO Expert Committee on Biological Standardization. Forty-third report. Geneva, World Health Organization, 1994, Annex 4 (WHO Technical Report Series, No. 840).
26. Requirements for rabies vaccine (inactivated) for human use produced in continuous cell lines. In: WHO Expert Committee on Biological Standardization. Forty-third report. Geneva, World Health Organization, 1994, Annex 5 (WHO Technical Report Series, No. 840).
27. Requirements for the use of animal cells as in vitro substrates for the production of biologicals. In: WHO Expert Committee on Biological Standardization. Forty-seventh report. Geneva, World Health Organization, 1998, Annex 1 (WHO Technical Report Series, No. 878).
28. Guidelines for national authorities on quality assurance for biological products. In: WHO Expert Committee on Biological Standardization. Forty-second report. Geneva, World Health Organization, 1992, Annex 2 (WHO Technical Report Series, No. 822).
29. Regulation and licensing of biological products in countries with newly developing regulatory authorities. In: WHO Expert Committee on Biological Standardization. Forty-fifth report. Geneva, World Health Organization, 1995, Annex 1 (WHO Technical Report Series, No. 858).
30. Report. Discussion on WHO requirements for rabies vaccine for human use: potency assay, World Health Organization, Geneva, Switzerland, 20 May 2003. Geneva, World Health Organization, 2003 (http://www.who.int/biologicals/ publications/meetings/areas/vaccines/rabies/en/ Rabies%20vaccine%20meeting%20Final%20May%202003.pdf, accessed 15 April 2005).
31. Report. Discussion on WHO requirements for rabies vaccine for human use, World Health Organization, Geneva, Switzerland, 4-5 May 2004. Geneva, World Health Organization, 2004 (http://www.who.int/biologicals/publications/meetings/ areas/vaccines/rabies/en/Rabies%20vaccine%20meeting%20Final %20May%202004.pdf, accessed 15 April 2005).
32. WHO Expert Committee on Rabies. Seventh report. Geneva, World Health Organization, 1984 (WHO Technical Report Series, No. 709).
33. Guidelines for clinical evaluation of vaccines: regulatory expectations. In: WHO Expert Committee on Biological Standardization, Fifty-second report. Geneva, World Health Organization, 2004, Annex 1 (WHO Technical Report Series No. 924).
34. Guidelines for nonclinical evaluation of vaccines. In: WHO Expert Committee on Biological Standardization. Fifty-fourth report. Geneva, World Health Organization (WHO Technical Report Series, in press) (http://www.who.int/ biologicals/publications/en/nonclinical_evaluation_vaccines_nov_2003.pdf).
35. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. Geneva, World Health Organization, 1997 (WHO/EMC/ZOO/96.6).
36. Report of a WHO Consultation on Intradermal Application of Human Rabies Vaccines, Geneva, Switzerland, 13-14 March 1995. Geneva, World Health Organization, 1995 (WHO/Rab.Res./95.47).
37. Report of informal discussions on intradermal application of modern rabies vaccines for human post-exposure treatment, Geneva, Switzerland, 22 January 1993. Geneva, World Health Organization, 1993 (WHO/Rab.Res./93.41).
38. Dodet B, Meslin F-X, eds. Fourth international symposium on rabies control in Asia. Symposium proceedings, 5-9 March 2001, Hanoi, Viet Nam. Montrouge, John Libbey Eurotext, 2001.
39. Field application of oral rabies vaccines for dogs. Report of a WHO Consultation organized in collaboration with the Office International des Epizooties (OIE), Geneva, Switzerland, 20-22 July 1998. Geneva, World Health Organization, 1998 (WHO/EMC/ZDI/98.15).
40. Report of the Fifth Consultation on Oral Immunization of Dogs against Rabies. Organized by WHO with the participation of the Office International des Epizooties (OIE), Geneva, 20-22 June 1994. Geneva, World Health Organization, 1994 (WHO/Rab.Res./94.45).
41. Report of a WHO Consultation on Requirements and Criteria for Field Trials on Oral Rabies Vaccination of Dogs and Wild Carnivores, Geneva, 1-2 March 1989. Geneva, World Health Organization, 1989 (WHO/Rab.Res./89.32).
42. Report of the Fourth WHO Consultation on Oral Immunization of Dogs against Rabies, Geneva, 14-15 June 1993. Geneva, World Health Organization, 1993 (WHO/Rab.Res./93.42).
43. Vaughn JB, Gerhardt P, Peterson JCD. Excretion of street rabies virus in saliva of cats. JAMA: the Journal of the American Medical Association, 1963, 184:705-708.
44. Vaughn JB, Newell KW. Excretion of street virus in saliva of dogs. JAMA: the Journal of the American Medical Association, 1965, 193:363-368.
45. WHO strategies for the control and elimination of rabies in Asia. Report of a WHO interregional consultation. Geneva, Switzerland, 17-21 July 2001. Geneva, World Health Organization, 2002 (WHO/CDS/CSR/EPH/2002.8).
46. Matter HC et al. Study of the dog population and the rabies control activities in the Mirigama area of Sri Lanka. Acta Tropica, 2000, 75(1):95-108.
47. Guidelines for dog population management. Geneva, World Health Organization/World Society for the Protection of Animals, May 1990 (WHO/ZOON/90.165).
48. King AA et al., eds. Historical perspectives of rabies in Europe and the Mediterranean Basin. Paris, World Organisation for Animal Health, 2004.
49. Report of WHO/APHIS Consultation on Baits and Baiting Delivery Systems for Oral Immunization of Wildlife against Rabies. Colorado State University, Fort Collins, Colorado, 10-12 July 1990. Geneva, World Health Organization, 1990 (WHO/Rab. Res./90.36).
50. The oral vaccination of foxes against rabies. Report of the Scientific Committee on Animal Health and Animal Wildlife. Adopted on 23 October 2002. European Commission (http://europa.eu.int/comm/food/fs/sc/scah/outcome_en.html, accessed 15 April 2005).
51. Terrestrial animal health code, 11th ed. Paris, World Organisation for Animal Health, 2004, Part 2, Chapter 2.2.5 (http://www.oie.int/eng/normes/mcode/ en_chapitre_2.2.5.htm, accessed 31 March 2005).
52. Briggs DJ et al. A comparison of two serological methods for detecting the immune response after rabies vaccination in dogs and cats being exported to rabies-free areas. Biologicals, 1998, 26(4):347-355.
53. Cliquet F, Aubert M, Sagné L. Development of a fluorescent antibody virus neutralisation test (FAVN) for the quantitation of rabies-neutralising antibody. Journal of Immunological Methods, 1998, 212:79-87.
54. King A, ed. Rabies in eastern and southern Africa - a seminar organized by the Central Veterinary Research Institute, Lusaka, cosponsored by FAO, WHO and OIE, Lusaka, Zambia, 2-5 June 1992. Lyon, Fondation Marcel Mérieux, 1992 (available at http://www.who.int/rabies/international_symposia).
55. Proceedings of the Southern and Eastern Rabies Group international symposium. Pietermartzburg, South African Republic, 29-30 April 1993 (available at http://www.who.int/rabies/international_symposia).
56. Bingham J, Bishop GC, King and A, eds. Proceedings of the third international conference of the Southern and Eastern African Rabies Group. Harare, Zimbabwe, 7-9 March 1995. Lyon, Fondation Marcel Mérieux, 1996 (available at http://www.who.int/rabies/international_symposia).
57. Kitala P et al., eds. Proceeding of the Southern and Eastern African Rabies Group Meeting, Nairobi, Kenya, 4-6 March 1997. Lyon, Fondation Marcel Mérieux, 1998 (available at http://www.who.int/rabies/international_ symposia).
58. Rutebarika C et al., eds. Proceedings of the Southern and Eastern African Rabies Group/World Health Organization meeting, Entebbe, Uganda, 29-31 March 1999. Lyon, Fondation Marcel Mérieux, 2000 (available at http://www.who.int/rabies/international_symposia).
59. King A, Barrat J, eds. Proceedings of the Southern and Eastern African Rabies Group/World Health Organization meeting, Lilongwe, Malawi, 18-22 June 2001 (available at http://www.who.int/rabies/international_symposia).
60. Barrat J, Nel L, eds. Proceedings of the Southern and Eastern African Rabies Group/World Health Organization meeting, Ezulwini, Swaziland, 12-15 May 2003 (available at http://www.who.int/rabies/international_symposia).
61. Report of the workshop on rabies control in Asian countries. Samarkand, September 19-21, 1989. Lyon, Fondation Marcel Mérieux, 1990.
62. Proceedings of the symposium on rabies control in Asia. Jakarta, Indonesia, 27-30 April 27-30, 1993. Lyon, Fondation Marcel Mérieux, 1994.
63. Dodet B, Meslin FX, eds. Rabies control in Asia. Third international symposium on rabies control in Asia. 11-15 September 1996, Wuhan, China. Paris, Elsevier, 1997.
64. WHO meeting of rabies control in middle and east European Countries, in Kosice Slovakia, September 25th-27th 2002 (organized by the WHO Collaborating Centre for Rabies Surveillance and Research). Insel Riems, Friedrich Loeffler Institute (http://www.fli.bund.de/).
65. Bahloul C et al. Perrin DNA-based immunisation for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine, 1998, 16:417-425.
66. Jallet C et al. Chimeric lyssavirus glycoproteins with increased immunological potential. Journal of Virology, 1999, 73:225-233.
67. Desmezières E et al. Lyssavirus glycoproteins expressing immunologically potent B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines. Journal of General Virology, 1999, 80:2343-2351.